Showing 151-160 of 6037 results for "".
UV Talk: Men and Women
https://practicaldermatology.com/topics/skin-cancer-photoprotection/uv-talk-men-and-women/18695/Talk to every patient about UV avoidance, but tailor your patient to each patient's needs and behavior, says Joel L. Cohen, MD. Consider the patient's sex when making recommendations. Watch now to get Dr. Cohen's tip for endurance athletes.Inbound Marketing: Why You Need a Strategy
https://practicaldermatology.com/topics/practice-management/inbound-marketing/18782/Focus on cultivating interactive marketing messages to show your audience what your practice is all about and what value it offers your target audience. "In your face" marketing is a thing of the past. Learn three strategies for successful inbound marketing for a medical practice in this Ekwa.com EWondering with Steve and Sabrina: Mexico
https://practicaldermatology.com/topics/skin-cancer-photoprotection/wondering-with-steve-and-sabrina-mexico/18646/Traveling in the Baja Desert, Steven Dayan, MD and Sabrina Fabi, MD discover the benefits of Lomboy, a plant that can be used for sun protection. While natural isn't always better (think poison ivy), Lomboy is widely used to protect the skin because it produces a thick white paste. (C) Steven Dayan,Seeing the Whole Picture, and When to Say "No"
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/seeing-the-whole-picture-and-when-to-say-no-/19084/You can turn patients down and still thrive. Heidi Waldorf, MD, FAAD and Steven Dayan, MD, FACS, Co-Chief Medical Editors of Modern Aesthetics®magazine, explain why and how you can tell patients "no," and offer tips for directing patients to a more appropriate intervention.Sunscreen Water Seems All Washed Up; Fake Cosmeceuticals Raise Concerns
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-sunscreen-water-seems-all-washed-up-fake-cosmeceuticals-raise-concerns/19119/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine we take a look at drinkable sunscreen and school bans on sunscreens, get an update on Vegas Cosmetic Surgery, and meet the new face of AMBI skincare. Plus, our DermFocus investigates the problem of counterfeit cosPart 3, 1726 nm lasers: How to talk to patients about incorporating the 1726 nm wavelength lasers into their treatment regimens: Hint is to be patient
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24341/Chapter 3 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about how to talk to patients about incorporating the 1726 nm wavelength lasers into their treatment regimens: Hint is toPart 4, 1726 nm lasers: Handling referred patients who are already on different treatment regimens
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24342/Chapter 4 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about handling referred patients who are already on different treatment regimens.Part 7, 1726 nm lasers: When a patient doesn’t improve: Doctors discuss “pearls” of wisdom
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24345/Chapter 7 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about when a patient doesn’t improve: Doctors discuss “pearls” of wisdom.The Impact of Clascoterone Topical Cream, 1%: The US Experience 4 Years After Approval and Clinical Expectations for Acne Patients in Other Regions of the World
https://practicaldermatology.com/topics/acne-rosacea/Impact-Clascoterone-Topical-Cream/32830/Clascoterone topical cream, 1% (Winlevi), approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older. The safety and efficacy were supported by two succeNoah Worcester 2024: Dr. Bettencourt on Beach Vacations
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-bettencourt-beach-vacations/24591/Miriam Bettencourt, MD, summarizes her lecture about problems that can be encountered during beach vacations at the 2024 Noah Worcester Dermatological Society meeting.